Guardian Wealth Advisors (North Carolina)’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $484K | Sell |
1,193
-171
| -13% | -$69.3K | 0.03% | 200 |
|
|
2025
Q1 | $679K | Sell |
1,364
-27
| -2% | -$13.4K | 0.05% | 158 |
|
|
2024
Q4 | $724K | Buy |
1,391
+209
| +18% | +$109K | 0.06% | 157 |
|
|
2024
Q3 | $731K | Sell |
1,182
-36
| -3% | -$22.3K | 0.08% | 129 |
|
|
2024
Q2 | $674K | Buy |
1,218
+15
| +1% | +$8.3K | 0.08% | 129 |
|
|
2024
Q1 | $699K | Buy |
1,203
+112
| +10% | +$65.1K | 0.09% | 126 |
|
|
2023
Q4 | $579K | Buy |
1,091
+11
| +1% | +$5.84K | 0.09% | 120 |
|
|
2023
Q3 | $547K | Buy |
1,080
+7
| +0.7% | +$3.55K | 0.09% | 114 |
|
|
2023
Q2 | $560K | Buy |
1,073
+144
| +16% | +$75.2K | 0.1% | 110 |
|
|
2023
Q1 | $536K | Buy |
929
+44
| +5% | +$25.4K | 0.09% | 108 |
|
|
2022
Q4 | $488K | Sell |
885
-47
| -5% | -$25.9K | 0.09% | 114 |
|
|
2022
Q3 | $473K | Sell |
932
-81
| -8% | -$41.1K | 0.09% | 110 |
|
|
2022
Q2 | $551K | Buy |
1,013
+488
| +93% | +$265K | 0.1% | 101 |
|
|
2022
Q1 | $310K | Sell |
525
-962
| -65% | -$568K | 0.13% | 118 |
|
|
2021
Q4 | $992K | Buy |
+1,487
| New | +$992K | 0.43% | 46 |
|